{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462263142
| IUPAC_name = 17α-Ethynylestra-4,9,11-trien-17β-ol-3-one
| image = Norgestrienone.svg
| width = 250

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 848-21-5
| ATC_prefix = G03
| ATC_suffix = AC07
| PubChem = 13313
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 12749
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 89386PYU9O 
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07220

<!--Chemical data-->
| C=20 | H=22 | O=2 
| molecular_weight = 294.387 g/mol
| smiles = O=C4\C=C3/C(=C2/C=C\[C@]1([C@@H](CC[C@]1(C#C)O)[C@@H]2CC3)C)CC4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H22O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,8,10,12,17-18,22H,4-7,9,11H2,2H3/t17-,18+,19+,20+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GVDMJXQHPUYPHP-FYQPLNBISA-N
| synonyms = RU-2010
}}

'''Norgestrienone''' ([[International Nonproprietary Name|INN]]) (brand name '''Ogyline''', '''Planor''', '''Miniplanor'''; former developmental code name '''RU-2010'''), also known as '''Δ<sup>9,11</sup>-norethisterone'''<ref name="LaverySanfilippo2012">{{cite book|author1=J.P. Lavery|author2=J.S. Sanfilippo|title=Pediatric and Adolescent Obstetrics and Gynecology|url=https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA236|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4612-5064-7|pages=236–}}</ref> or '''17α-ethynyltrienolone''' ('''17α-ethynyltrenbolone'''), as well as '''17α-ethynylestra-4,9,11-trien-17β-ol-3-one''', is a [[steroid]]al [[progestin]] related to [[norethisterone]] that is used as a [[hormonal contraceptive]], sometimes in combination with [[ethinylestradiol]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=887–}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA202|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=202–}}</ref><ref>{{Cite journal | last1 = Diaz | first1 = S. | last2 = Pavez | first2 = M. | last3 = Quinteros | first3 = E. | last4 = Diaz | first4 = J. | last5 = Robertson | first5 = D. N. | last6 = Croxatto | first6 = H. B. | title = Clinical trial with subdermal implants containing norgestrienone | journal = Contraception | volume = 18 | issue = 4 | pages = 429–440 | year = 1978 | pmid = 720075 | doi=10.1016/0010-7824(78)90027-6}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA751|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=751–}}</ref> It was developed by [[Roussel Uclaf]] and is registered for use only in [[France]].<ref name="IndexNominum2000" /><ref name="McGuire2000">{{cite book|author=John L. McGuire|title=Pharmaceuticals, 4 Volume Set|url=https://books.google.com/books?id=uG9qAAAAMAAJ|year=2000|publisher=Wiley|isbn=978-3-527-29874-7|page=1580,1599}}</ref> Under the brand name '''Planor''', it is or was marketed in France as 2&nbsp;mg norgestrienone and 50&nbsp;μg ethinylestradiol tablets.<ref name="HumansOrganization2007">{{cite book|author1=IARC Working Group on the Evaluation of Carcinogenic Risks to Humans|author2=World Health Organization|author3=International Agency for Research on Cancer|title=Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy|url=https://books.google.com/books?id=aGDU5xibtNgC&pg=PA455|year=2007|publisher=World Health Organization|isbn=978-92-832-1291-1|pages=455–}}</ref> Norgestrienone has been found to possess similar [[affinity (pharmacology)|affinity]] for the [[progesterone receptor]] and [[androgen receptor]],<ref name="pmid1291626">{{cite journal | vauthors = Loughney DA, Schwender CF | title = A comparison of progestin and androgen receptor binding using the CoMFA technique | journal = J. Comput. Aided Mol. Des. | volume = 6 | issue = 6 | pages = 569–81 | year = 1992 | pmid = 1291626 | doi = 10.1007/bf00126215| url = }}</ref> and in accordance, has some [[androgen]]ic activity.<ref name="Axelrod1982">{{cite book|author=Julius Axelrod|title=Biochemical Actions of Hormones|url=https://books.google.com/books?id=AxpPAQAAIAAJ|date=1 January 1982|publisher=Academic Press|isbn=978-0-12-452809-3}}</ref><ref name="LauritzenStudd2005">{{cite book|author1=Christian Lauritzen|author2=John W. W. Studd|title=Current Management of the Menopause|url=https://books.google.com/books?id=WD7S7677xUUC&pg=PA45|date=22 June 2005|publisher=CRC Press|isbn=978-0-203-48612-2|pages=45–}}</ref><ref name="GiulioMonosson2012">{{cite book|author1=R.T. Di Giulio|author2=E. Monosson|title=Interconnections Between Human and Ecosystem Health|url=https://books.google.com/books?id=dQ1JCAAAQBAJ&pg=PA60|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-009-1523-7|pages=60–}}</ref> The drug was first described in the literature in 1965.<ref name="LauritzenStudd2005" /> [[Gestrinone]] is the 13β-[[ethyl group|ethyl]] variant or 18-[[methyl group|methyl]] derivative of norgestrienone.<ref name="GomelBrill2010">{{cite book|author1=Victor Gomel|author2=Andrew Brill|title=Reconstructive and Reproductive Surgery in Gynecology|url=https://books.google.com/books?id=C4TOBQAAQBAJ&pg=PA90|date=27 September 2010|publisher=CRC Press|isbn=978-1-84184-757-3|pages=90–}}</ref>

==See also==
* [[Altrenogest]]
* [[Metribolone]]
* [[Trenbolone]]

==References==
{{reflist|30em}}

{{Progestogens and antiprogestogens}}
{{Androgens and antiandrogens}}
{{Progesterone receptor modulators}}
{{Androgen receptor modulators}}

[[Category:Androgens and anabolic steroids]]
[[Category:Estranes]]
[[Category:Progestogens]]


{{genito-urinary-drug-stub}}
{{steroid-stub}}